Curcumin in Alzheimer's Disease and Depression: Therapeutic Potential and Mechanisms of Action

被引:4
|
作者
Oliveira, Jordan Teixeira [1 ]
Pieniz, Simone [1 ]
机构
[1] Univ Fed Pelotas, Dept Nutr, Pelotas, RS, Brazil
关键词
Curcuma longa; turmeric; polyphenol; BDNF; Dementia; neurological disease; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; OXIDATIVE DAMAGE; MESSENGER-RNA; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; RATS INVOLVEMENT; SMALL-INTESTINE; BDNF LEVELS;
D O I
10.1590/1678-4324-2024220004
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Curcumin is a polyphenol present in Curcuma longa, a root used in Asian cuisine for thousands of years, and it has several medicinal properties, acting as an antioxidant, anti-inflammatory, anticancer, among others. Polyphenols generally have the ability to restore BDNF (Brain Derived Neurotrophic Factor) levels, which is a very important neurotrophin in controlling neuronal development and survival, when they are impaired, offering a therapeutic effect. The aim of this study was to evaluate the effects of curcumin in Alzheimer's disease and Depression, which has as its main pathogenesis the reduction of BDNF levels, monoamine levels, increased oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, verifying its therapeutic capacity. Therefore, a literature review was performed in the Scholar Google, ScienceDirect, and PubMed databases. The data analyzed demonstrated that curcumin supplementation is able to restore BDNF levels in Alzheimer's disease and depression, in addition to modulating monoamines and reducing oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, improving their symptoms.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] The Mechanisms of Action of Curcumin in Alzheimer's Disease
    Tang, Mengxi
    Taghibiglou, Changiz
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1003 - 1016
  • [2] Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?
    Ahmed, Touqeer
    Gilani, Anwarul-Hassan
    PHYTOTHERAPY RESEARCH, 2014, 28 (04) : 517 - 525
  • [3] Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties
    Liu, Jinman
    Li, Tianyao
    Zhong, Guangcheng
    Pan, Yaru
    Gao, Minghuang
    Su, Shijie
    Liang, Yong
    Ma, Cuiru
    Liu, Yuanyue
    Wang, Qi
    Shi, Qing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [4] Action Mechanisms of Curcumin in Alzheimer's Disease and Its Brain Targeted Delivery
    Ege, Duygu
    MATERIALS, 2021, 14 (12)
  • [5] Galanin: Neurobiologic mechanisms and therapeutic potential for Alzheimer's disease
    Counts, SE
    Perez, SE
    Kahl, U
    Bartfai, T
    Bowser, RP
    Deecher, DC
    Mash, DC
    Crawley, JN
    Mufson, EJ
    CNS DRUG REVIEWS, 2001, 7 (04): : 445 - 470
  • [6] Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease
    Wolfe, Michael S.
    MOLECULES, 2021, 26 (02):
  • [7] Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
    Zheng, Lingyan
    Wu, Sichen
    Jin, Haichao
    Wu, Jiaqi
    Wang, Xiaole
    Cao, Yuxiao
    Zhou, Zhihao
    Jiang, Yaona
    Li, Linhong
    Yang, Xinyue
    Shen, Qing
    Guo, Shunyuan
    Shen, Yuejian
    Li, Changyu
    Ji, Liting
    PHYTOMEDICINE, 2023, 116
  • [8] Syndecans in Alzheimer's disease: pathogenetic mechanisms and potential therapeutic targets
    Balistreri, Carmela Rita
    Monastero, Roberto
    NEURAL REGENERATION RESEARCH, 2025, 20 (09) : 2594 - 2595
  • [9] Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target
    Wang, Qinqin
    Yao, Hongmei
    Liu, Wenyan
    Ya, Bailiu
    Cheng, Hongju
    Xing, Zhenkai
    Wu, Yili
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [10] Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin
    Ray, Balmiki
    Lahiri, Debomoy K.
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (04) : 434 - 444